GenScript expands peptide production capabilities to include neoantigen peptides and APIs

With over 20 years of expertise in custom peptide services, GenScript is a global leader in delivering high-quality peptides for drug discovery and development. The company specializes in neoantigen peptides for personalized therapies, as well as complex modified peptides, including innovative cyclic peptides, peptide conjugates, and other customized peptide formats. Expanding its capabilities, GenScript now offers fast-track cGMP production of neoantigen peptides and peptide active pharmaceutical ingredients (APIs) from its state-of-the-art life sciences manufacturing facility in Zhenjiang, ensuring rapid, reliable, and regulatory-compliant supply for customers worldwide.